Facilities - Oncology
MSN Oncology has started its operations in 2010. The API portfolio covers 35 products across various types of cancer.
The dedicated team with a passion to excel & an average experience of 10 years handles products ranging from anti-neoplastics to tyrosine kinase inhibitors, to anti-androgens to alkylating agents to proteasome inhibitors to depsipeptides. Since its` inception, the MSN Oncology has filed 2 USDMFs & ready to file 10 more.